Incidence of hypoglycemia in patients with type 2 diabetes treated with gliclazide versus DPP-4 inhibitors during Ramadan: A meta-analytical approach

MBANYA J. C., AL-SIFRI S., ABDEL-RAHIM A., Satman I.

DIABETES RESEARCH AND CLINICAL PRACTICE, vol.109, no.2, pp.226-232, 2015 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Review
  • Volume: 109 Issue: 2
  • Publication Date: 2015
  • Doi Number: 10.1016/j.diabres.2015.04.030
  • Journal Name: DIABETES RESEARCH AND CLINICAL PRACTICE
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.226-232
  • Keywords: Ramadan, Diabetes, Gliclazide, GLUCOSE CONTROL, INSULIN SECRETAGOGUES, MUSLIM PATIENTS, DOUBLE-BLIND, SULFONYLUREA, VILDAGLIPTIN, SITAGLIPTIN, MANAGEMENT, MORTALITY, OUTCOMES
  • Istanbul University Affiliated: Yes

Abstract

Aim: Hypoglycemia can be a concern for patients with type 2 diabetes when fasting during Ramadan. In this analysis, we assessed the incidence of symptomatic hypoglycemic events in fasting patients treated with gliclazide or dipeptidyl peptidase-4 (DPP-4) inhibitors.